News
30 Apr 2026, 19:10
FDA Approval and Fundraising: BioticsAI Founder Reveals the Reality of Building a Healthcare AI Startup

BitcoinWorld FDA Approval and Fundraising: BioticsAI Founder Reveals the Reality of Building a Healthcare AI Startup Building a healthcare AI startup demands more than just a great idea. It requires navigating strict regulations, securing funding, and maintaining team morale over long timelines. Robhy Bustami, co-founder and CEO of BioticsAI, knows this firsthand. His company develops an AI copilot for ultrasound that detects fetal abnormalities. In January, BioticsAI gained FDA approval, a critical milestone that allows the startup to deploy its technology in hospitals. This article explores the challenges and strategies behind FDA approval, fundraising, and building in healthcare. FDA Approval: A Milestone for BioticsAI BioticsAI received FDA approval in January, marking a turning point for the startup. This clearance enables the company to begin rolling out its AI copilot in hospitals. The FDA process is often seen as a black box, but Bustami emphasizes early engagement with regulators. Pre-submission meetings helped the team align on study design and expectations. This proactive approach reduced uncertainty and streamlined the approval process. From day one, BioticsAI integrated clinical validation, regulatory strategy, and product development. Instead of building first and figuring out regulation later, the team worked closely with clinicians. They collected large-scale datasets and ran structured clinical studies before submission. This rigorous approach was key to securing FDA approval. Fundraising Challenges in Healthcare AI Fundraising for a healthcare AI startup presents unique challenges. Investors often ask a simple question: What if the FDA says no? This risk makes it harder to secure funding. BioticsAI started scrappy, building an early prototype for under $100,000. That milestone helped them win Bitcoin World Startup Battlefield in 2023, bringing early visibility and credibility. Bustami notes that investors need to see a clear path to revenue. With FDA approval, BioticsAI can now generate revenue by deploying its technology in hospitals. This shift makes the startup more attractive to investors. The company plans to expand beyond obstetrics into broader areas of reproductive health. Building a Culture of Alignment Long timelines create a different kind of challenge: keeping the team motivated. At BioticsAI, building a culture of alignment across engineers, clinicians, and researchers was crucial. Bustami emphasizes the importance of celebrating small wins on the R&D side, from clinical studies to new healthcare partnerships. “Making sure everyone is completely aligned, even if it’s outside of their technical scope,” Bustami said, “constantly seeing wins on the R&D side.” This approach helps maintain morale when the biggest milestone is years away. Navigating Regulatory Red Tape Healthcare startups must navigate significant red tape. BioticsAI approached product development with FDA approval in mind from the start. This meant integrating regulatory strategy into every stage of development. The team worked closely with clinicians to ensure their product met clinical needs and regulatory standards. Early engagement with regulators through pre-submission meetings helped align expectations. This proactive approach reduced the risk of delays and rejection. Bustami advises other founders to not navigate the FDA process blindly. The Reality of Building in Healthcare Building in healthcare is a long game. It requires patience, discipline, and a willingness to operate in uncertainty. For founders willing to take that path, the reward isn’t just a successful company. It’s the chance to build something that genuinely changes how care is delivered. BioticsAI’s journey illustrates the importance of integrating regulatory strategy from the start. The company’s FDA approval opens doors to deployment and revenue generation. This milestone also validates the startup’s approach to building a healthcare AI product. Conclusion BioticsAI’s FDA approval marks a critical milestone for the healthcare AI startup. The company’s journey highlights the importance of early regulatory engagement, integrated product development, and team alignment. For founders building in healthcare, the path is long but rewarding. BioticsAI now enters a new phase: deployment in hospitals, with plans to expand into broader reproductive health areas. The reality of building in healthcare requires patience, discipline, and a willingness to navigate uncertainty. But for those who succeed, the impact on patient care is profound. FAQs Q1: What is BioticsAI? BioticsAI is a healthcare AI startup that develops an AI copilot for ultrasound to detect fetal abnormalities. Q2: When did BioticsAI receive FDA approval? BioticsAI received FDA approval in January, allowing the company to deploy its technology in hospitals. Q3: How did BioticsAI approach FDA approval? The startup integrated clinical validation, regulatory strategy, and product development from day one, working closely with clinicians and regulators. Q4: What fundraising challenges did BioticsAI face? Investors were concerned about FDA risk. The startup built an early prototype for under $100,000 and won Bitcoin World Startup Battlefield in 2023 to gain credibility. Q5: How does BioticsAI keep its team motivated? By building a culture of alignment and celebrating small wins on the R&D side, such as clinical studies and healthcare partnerships. This post FDA Approval and Fundraising: BioticsAI Founder Reveals the Reality of Building a Healthcare AI Startup first appeared on BitcoinWorld .
30 Apr 2026, 16:26
MegaETH Token Launches as Ethereum Layer-2 Network's Novel Rewards System Is Tested

Ethereum layer-2 network MegaETH will unlock its native MEGA token over time, and reward it to users, as key benchmarks are met.
30 Apr 2026, 13:25
Tether Investments Proposes Major Bitcoin Merger for XXI and Strike

Tether Investments announced a strategic plan on Wednesday to transform Twenty-One Capital into an integrated bitcoin powerhouse through a series of proposed mergers with Strike and Elektron Energy. Key Takeaways: Tether Investments proposed a merger between XXI and Jack Mallers’ Strike on April 29, 2026. The deal integrates Elektron Energy’s 50 EH/s mining fleet to
30 Apr 2026, 13:21
XLM Technical Analysis 30 April 2026: Risk and Stop Loss

XLM is squeezed in a narrow band at $0.16 in a downtrend, with $0.1557 support as the critical risk point. The bearish target of $0.1137 versus the bullish reward of $0.2097 is unbalanced; protect ...
30 Apr 2026, 12:15
Hyperscale Data Q1 Revenue Surges 76% YoY to $44M, Boosts BTC Holdings Strategy

BitcoinWorld Hyperscale Data Q1 Revenue Surges 76% YoY to $44M, Boosts BTC Holdings Strategy Hyperscale Data (NYSE: GPUS) has reported a stunning 76% year-over-year increase in preliminary Q1 2026 revenue, reaching approximately $44 million. This significant jump from $25 million in the same period last year highlights the company’s aggressive expansion in both data center operations and cryptocurrency mining. The announcement, made on April 26, 2026, from New York, positions Hyperscale Data as a key player in the evolving digital infrastructure and digital asset landscape. Hyperscale Data Q1 Revenue Breakdown: Mining and Beyond The company’s cryptocurrency mining revenue alone contributed roughly $5 million to the quarterly total. While this represents a portion of the overall figure, it underscores the growing importance of digital asset generation within Hyperscale Data’s diversified business model. Analysts note that the remaining $39 million likely stems from its core data center services, including colocation, cloud, and AI infrastructure solutions. This dual revenue stream provides a buffer against volatility in the crypto market while capitalizing on the sustained demand for high-performance computing. Bitcoin Holdings Strategy: Targeting $100 Million As of April 26, 2026, Hyperscale Data held 675.35 Bitcoin (BTC), valued at approximately $53.1 million. The company has publicly stated its ambition to increase its BTC holdings to $100 million. This strategy aligns with a growing trend among publicly traded companies to use Bitcoin as a treasury reserve asset. By holding a significant amount of the world’s leading cryptocurrency, Hyperscale Data aims to hedge against inflation and generate long-term shareholder value. The move also signals confidence in Bitcoin’s future price appreciation and its role as a store of value. GPUS Stock Performance and Market Reaction Following the revenue announcement, GPUS stock experienced a notable uptick in after-hours trading. Investors reacted positively to the strong top-line growth and the clear strategic roadmap for Bitcoin accumulation. Market analysts have revised their price targets upward, citing the company’s ability to scale revenue while maintaining a disciplined approach to digital asset management. The 76% revenue surge far exceeds consensus estimates, which had predicted a more modest 40-50% growth. This outperformance has placed Hyperscale Data firmly on the radar of institutional investors seeking exposure to both AI infrastructure and digital assets. Context: The Broader Crypto Mining Landscape in 2026 The first quarter of 2026 has been a period of consolidation for the cryptocurrency mining industry. Following the 2024 Bitcoin halving, which reduced block rewards, many miners have struggled to maintain profitability. However, companies with diversified revenue streams, like Hyperscale Data, have fared better. The company’s ability to generate significant revenue from non-mining operations provides a competitive edge. Additionally, the recent approval of spot Bitcoin ETFs has increased institutional demand for Bitcoin, supporting its price and making holdings more valuable. Hyperscale Data’s strategy of accumulating BTC rather than selling it immediately for operational costs is a bet on continued price appreciation. Key Financial Metrics and Comparison Metric Q1 2026 Q1 2025 Change Total Revenue $44 million $25 million +76% Crypto Mining Revenue $5 million Not disclosed N/A BTC Holdings 675.35 BTC Not disclosed N/A BTC Value (as of Apr 26) $53.1 million Not disclosed N/A The table above clearly illustrates the dramatic revenue expansion. The lack of prior-year data for crypto mining and BTC holdings suggests these initiatives have gained significant traction only recently. This indicates a strategic pivot that is now paying off. Expert Analysis and Future Outlook Industry experts view Hyperscale Data’s performance as a bellwether for the convergence of traditional data center operations and cryptocurrency mining. “The company is effectively operating two high-growth businesses under one roof,” explains a senior analyst at a leading financial research firm. “Their data center business benefits from the AI boom, while their mining operations give them direct exposure to Bitcoin’s upside. This dual approach reduces risk and enhances returns.” The company’s stated goal of reaching $100 million in BTC holdings suggests continued aggressive accumulation. If Bitcoin prices remain stable or increase, this could significantly boost the company’s balance sheet and market capitalization. Timeline of Hyperscale Data’s Growth 2024: Company begins expanding data center capacity for AI workloads. 2025: Initial foray into cryptocurrency mining with small-scale operations. Q1 2026: Revenue surges 76% YoY; BTC holdings reach $53.1 million. Target: Achieve $100 million in BTC holdings by end of 2026. This timeline demonstrates a rapid and deliberate expansion strategy. The company has moved quickly to capitalize on market opportunities, positioning itself for sustained growth. Conclusion Hyperscale Data’s Q1 2026 revenue surge of 76% to $44 million marks a significant milestone for the company. The combination of strong data center revenue and a growing cryptocurrency mining operation, coupled with a strategic Bitcoin accumulation plan, has created a powerful growth engine. With a clear target of $100 million in BTC holdings, Hyperscale Data is positioning itself as a leader in the digital infrastructure and digital asset space. Investors and industry observers will be watching closely to see if the company can maintain this momentum throughout the remainder of the year. FAQs Q1: What is Hyperscale Data’s ticker symbol? A1: Hyperscale Data trades on the New York Stock Exchange under the ticker symbol GPUS. Q2: How much Bitcoin does Hyperscale Data currently hold? A2: As of April 26, 2026, the company holds 675.35 Bitcoin, valued at approximately $53.1 million. Q3: What is the company’s target for Bitcoin holdings? A3: Hyperscale Data aims to increase its Bitcoin holdings to $100 million. Q4: How much revenue did Hyperscale Data generate from cryptocurrency mining in Q1 2026? A4: The company reported approximately $5 million in cryptocurrency mining revenue for the first quarter of 2026. Q5: Why is Hyperscale Data’s revenue growth significant? A5: The 76% year-over-year growth significantly exceeded market expectations and demonstrates the success of the company’s dual strategy of data center services and cryptocurrency mining. This post Hyperscale Data Q1 Revenue Surges 76% YoY to $44M, Boosts BTC Holdings Strategy first appeared on BitcoinWorld .
30 Apr 2026, 12:00
Best Alternative Staking Protocols for DeFi Yield in 2026

Standard staking pays one rate from one source. Lock ETH, secure the network, collect validator rewards. That model still works, but DeFi staking yield now extends into four distinct categories, each drawing returns from a different engine. The differences carry more weight in 2026 than they did a year ago. Volatile periods through 2025 stress-tested every model, and some held up better than others. Token emissions thinned out. Slashing exposure stacked higher than expected in restaking. Tokenized cashflow protocols quietly grew while the noisier categories made headlines. This piece maps the four categories of alternative staking protocols worth knowing in 2026, with current data on what each pays, where the yield originates, and how the structural risks shape each model. Treat it as a category map for picking where to put capital, not a ranked verdict. Top 4 Categories of Alternative Staking The four categories below pay yield from different sources and respond differently when market conditions shift. Liquid staking wraps ETH validator rewards in a transferable token. Restaking re-uses staked ETH to secure additional services. Tokenized financial yield routes capital into off-chain financial instruments. Production-linked yield draws returns from physical operations like commodity production. Each section below covers what the category does, who leads it, and what trade-off comes built into the model. 1. Liquid Staking: Lido and Rocket Pool Lido holds the dominant position in liquid staking, with TVL between $17 billion and $19 billion across 2026. Holders deposit ETH and receive stETH in return, a derivative token that accrues staking rewards while remaining usable across DeFi as collateral or liquidity. As of March 2026, stETH paid roughly 2.5% APR after Lido's 10% protocol fee. Rocket Pool serves as the decentralized counterpart, with rETH as its liquid token and a 16-ETH minimum for node operators. Both protocols draw yield from the same place: validator rewards on Ethereum's proof-of-stake consensus layer. The trade-off here is structural. As more ETH gets staked across the network, base validator rewards compress. Lido's share of staked ETH dropped to 22.8% by March 2026, reflecting both intensifying competition and broader liquid staking yield compression. The model still serves ETH-native holders well, but the yields available in 2026 are noticeably lower than in earlier cycles. 2. Restaking: EigenLayer EigenLayer dominates restaking with more than 93% market share. Its TVL has whipsawed through 2026, peaking at $19.7 billion before settling into the $9 billion. Liquid Restaking Tokens (LRTs) like EtherFi's eETH (around $5.5 billion in TVL) became the dominant access pattern, layering on top of EigenLayer's smart contracts. The mechanic stacks an additional yield engine on top of base ETH staking. Holders restake ETH or a liquid staking derivative to secure Actively Validated Services (AVSs), which are third-party protocols that pay for shared security. The current restaking premium sits around 3.87% on top of base ETH staking yield, though the figure swings with AVS demand. The honest trade-off is that restaking has been stress-tested in 2026, and the results are mixed. Slashing exposure stacks across services, multiplying risk in ways early adopters underestimated. The Kelp DAO exploit cost users roughly $300 million . The EIGEN token has lost more than 90% of its peak value, with persistent questions about whether AVS revenue can sustain yields once token emissions thin out. Anyone considering staking with extra rewards through restaking is taking on capital efficiency gains and structural fragility together. 3. Tokenized Financial Yield: Ondo and Maple Tokenized financial yield routes stake capital into off-chain financial instruments. Treasury bills and institutional credit are the two dominant flows in this category, wrapped in an on-chain token that tracks the underlying yield. Ondo Finance leads the Treasuries side. Its OUSG token is built on top of BlackRock's BUIDL fund, with tokenized US Treasuries paying approximately 4-5% in 2026. Maple Finance leads the credit side, with $4 billion in deposits and $2.4 billion in outstanding loans by January 2026, an eightfold increase across 2025. Maple's syrupUSDC pays a base APY of around 7-8%, sourced from interest paid by overcollateralized institutional borrowers. The mechanic is direct. Holders deposit stablecoins, receive a yield-bearing token (OUSG, syrupUSDC) that represents the position, and the protocols handle the off-chain leg. Custody and borrower underwriting sit with regulated counterparties. The trade-off is sensitivity to macro conditions. Treasury yields compress when the Federal Reserve cuts rates. Credit yields compress when institutional borrower demand softens. Both depend on the integrity of off-chain issuers and underwriters. Staking backed by real assets reduces some risks (no token emissions, no slashing) and introduces others (counterparty trust, rate exposure). 4. Production-Linked Yield: Ayni Gold Production-linked yield is the newest category in alternative staking, and the smallest by total value locked. Returns come from physical output, with commodity production currently the only operational example, converted into on-chain rewards. Ayni Gold is a DeFi protocol that turns gold mining output into on-chain yield, with stakers receiving PAXG rewards quarterly from mining production at the Minerales San Hilario concession in Peru. Each AYNI token represents 4 cm³ per hour of processing capacity at the concession site. Two licensed concessions are now active under the protocol, with the primary site registered with INGEMMET (No. 070011405) and a secondary one acquired in Q4 2025. The verification layer covers four independent providers. CertiK and PeckShield audited the smart contracts (both completed in October 2025). TurnKey handles institutional custody, and Kangari Consulting runs the geological assessments. The reward formula is published openly: PAXG reward = (AYNI_staked × Mining_output × Time_factor) − Costs − Success_Fee Settlement runs through Peru's banking system. Extracted gold is sold to local banks, the proceeds convert to fiat, and the fiat buys PAXG via Paxos for distribution to AYNI stakers proportional to stake size. The protocol burns 15% of accumulated success fees each quarter, gradually reducing the circulating supply. For holders evaluating PAXG yield staking as part of a broader portfolio, this is structurally distinct exposure. The position pays gold-backed DeFi yield that tracks operational variance, with mining output rising and falling, instead of rate environments or platform usage. The category is small in 2026 because it is the newest, but the structural difference is real. How the Four Categories Compare The four categories sit at different points on the yield-versus-risk map. Each has its own ceiling and its own failure mode. Category Yield source 2026 yield range Main structural risk Liquid staking Validator rewards ~2.5% (Lido) Yield compression as more ETH stakes Restaking AVS fees + emissions +3.87% over base ETH Slashing concentration, emission dependence Tokenized financial yield Interest from off-chain instruments 4-5% (Treasuries), 7-8% (credit) Macro rate sensitivity, counterparty risk Production-linked yield Physical production output Variable (mining-dependent) Operational variance Where Each Category Fits Different yield engines serve different holders. The summary below maps a clean fit for each: Liquid staking fits ETH-native holders who want staking yield that stays usable across DeFi as collateral, liquidity, or trading inventory Restaking fits holders comfortable with stacked slashing risk who believe AVS revenue models will mature into sustainable cash flows Tokenized financial yield fits holders who want returns tracking traditional fixed-income markets through an on-chain wrapper, with regulated off-chain custodians in the loop Production-linked yield fits holders who want yield decoupled from rate environments and platform activity, with returns tied to physical operations The four categories solve different allocation problems. Both production-linked yield and tokenized financial yield occupy the broader category of commodity backed DeFi when the underlying asset is physical, with returns traced back to real economic activity instead of token emissions or synthetic strategies. The right framing is not about which model wins in the abstract. It is which yield engine matches the portfolio. FAQ What is alternative staking in DeFi? Alternative staking refers to protocols that generate yield from sources other than standard validator rewards on a single blockchain. The four main categories in 2026 are liquid staking, restaking, tokenized financial yield, and production-linked yield, each drawing returns from a different engine. Which alternative staking model pays the highest yield? On-chain private credit through Maple's syrupUSDC pays around 7-8%, the highest among established categories. Production-linked yield is variable and tracks mining output. Headline yield rate is not the same as best fit, since each category carries different structural risks. What is production-linked yield staking? Yield generated from real-world production output instead of token emissions or financial instruments. Ayni Gold is the first protocol to bring this model on-chain, distributing PAXG rewards from mining production at licensed concessions in Peru, settled through Peru's banking system. Are alternative staking protocols safer than traditional staking? Each category carries different risks. Liquid staking adds smart contract exposure on top of validator risk. Restaking stacks, slashing exposure across services. Tokenized financial yield depends on issuer honesty. Production-linked yield depends on operational performance. Safety depends on which risks fit the portfolio. How does Ayni Gold differ from Lido or EigenLayer? Lido pays validator rewards from ETH staking. EigenLayer pays AVS fees plus token emissions on top of base ETH staking. Ayni Gold pays PAXG sourced from gold mining output at concessions in Peru. Three different yield engines, three different risk profiles. Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.








































